Xu Huang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Vascular Endothelial Growth Factor

Top Venues

ACS biomaterials science & engineering

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Signal transduction and targeted therapy

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Ruoyi Wang, Xu Huang, Xiaoxi Chen, Yingchao Zhang
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (6) (2024)
Ruoyi Wang, Xu Huang, Xiaoxi Chen, Yingchao Zhang
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (6) (2024)
Ruoyi Wang, Xu Huang, Xiaoxi Chen, Yingchao Zhang
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer. ACS biomaterials science & engineering 10 (6) (2024)
Ruoyi Wang, Xu Huang, Xiaoxi Chen, Yingchao Zhang
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer. ACS biomaterials science & engineering (2024)
Ruotao Li, Kai Liu, Xu Huang, Di Li, Jian-Xun Ding, Bin Liu, Xuesi Chen
Bioactive Materials Promote Wound Healing through Modulation of Cell Behaviors. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (10) (2022)
Duoyi Zhao, Xu Huang, Zhiyu Zhang, Jian-Xun Ding, Yan Cui, Xuesi Chen
Engineered nanomedicines for tumor vasculature blockade therapy. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 13 (3) (2021)
Jianhua Liu, Xu Huang, Jian-Xun Ding
Identification of MSA-2: An oral antitumor non-nucleotide STING agonist. Signal transduction and targeted therapy 6 (1) (2021)